HDGFL2 and infection: To improve the capacity of diagnostic tests to confirm subclinical infections and thereby identify and quantify the human reservoir at the PON, a cross-sectoral collaboration between researchers from the University of Florida’s Emerging Pathogens Institute and commercial partners produced an innovative, non-invasive saliva-based RDT capable of identifying novel, non-hrp2/3 parasite bio-markers [12].